Org Partners LLC Abb Vie Inc. Transaction History

Org Partners LLC

$397 Million
Q2 2025

A detailed history of Org Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Org Partners LLC holds 5,841 shares of ABBV stock, worth $1.12 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

5,841

Previous 4,065 43.69%

Holding current value

$1.12 Million

Previous $851,000 27.38%

% of portfolio

0.27%

Previous 0.25%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$170.16 - $206.27 $302,204 - $366,335	1,776 Added 43.69%	5,841 $1.08 Million
Q1 2025 Apr 21, 2025	SELL	$169.2 - $216.66 $1.36 Million - $1.74 Million	-8,031 Reduced 66.39%	4,065 $851,000
Q4 2024 Jan 10, 2025	BUY	$164.99 - $203.87 $418,249 - $516,810	2,535 Added 26.51%	12,096 $2.15 Million
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $2.05 Million - $2.49 Million	-12,515 Reduced 56.69%	9,561 $1.89 Million
Q2 2024 Jul 16, 2024	BUY	$154.79 - $180.76 $3.2 Million - $3.73 Million	20,654 Added 1452.46%	22,076 $3.79 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $4.38 Million - $4.99 Million	-27,402 Reduced 95.07%	1,422 $258,000
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $1.04 Million - $1.17 Million	7,525 Added 35.33%	28,824 $4.47 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $144,277 - $167,022	-1,080 Reduced 4.83%	21,299 $486 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $677,258 - $842,803	-5,111 Reduced 18.59%	22,379 $3.02 Billion
Q1 2023 Jun 01, 2023	BUY	$144.61 - $166.54 $3.98 Million - $4.58 Million	27,490 New	27,490 $4.39 Billion

Others Institutions Holding ABBV

# of Institutions

4,262

Shares Held

1.27B

Call Options Held

17M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $338B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.

Account